Tesamorelin 20mg

KEY BENEFITS

• Activates endogenous growth hormone (GH) release through native GHRH receptor signaling in research settings

• Supports physiologic, pulse-based GH secretion models

• Commonly explored in body-composition and metabolic signaling research

• Highly selective for the hypothalamic–pituitary growth hormone axis

• Frequently utilized in controlled endocrine and recovery-focused research protocols

Full Description

Tesamorelin is a synthetic analog of human growth hormone–releasing hormone (GHRH) designed to bind to GHRH receptors on pituitary somatotroph cells and stimulate the release of endogenous growth hormone. In laboratory and pre-clinical research, tesamorelin is widely used to investigate regulated activation of the growth hormone axis while preserving native feedback and control mechanisms.

Compared to shorter GHRH fragments, tesamorelin demonstrates enhanced structural stability and receptor interaction, making it well suited for studies requiring sustained and reproducible GH signaling. Its mechanism allows researchers to explore physiologic growth hormone pulsatility, downstream IGF-1 signaling, and endocrine regulation without introducing exogenous growth hormone.

Tesamorelin is commonly selected in research models focused on metabolic regulation, lipid and substrate utilization pathways, and recovery-related endocrine responses. These characteristics make it a frequent tool in studies examining the intersection of growth hormone signaling, body composition, and systemic metabolic function.

Commonly Explored For (Research Use Only)

• Growth hormone signaling and pulsatility research models

• Body composition and adipose metabolism pathway studies

• Endocrine and hypothalamic–pituitary axis investigations

• Metabolic and substrate-utilization signaling research

• Performance, recovery, and training-adaptation endocrine models